Status and phase
Conditions
Treatments
About
This is an open-label, extension, Phase II study to evaluate the long-term safety and efficacy of MRA in Patients with RA who were participated in Study MRA009JP.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patients with Class IV Steinbrocker functional activity at evaluation within 4 weeks before treatment with the study drug
Patients who received any of the following treatments between the start of preceding study and the registration of this study.
Primary purpose
Allocation
Interventional model
Masking
135 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal